Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NanoSilver Co., Ltd. is a South Korean biotechnology company specializing in the development and manufacturing of high-purity silver nanoparticles for medical and industrial applications. The company utilizes a proprietary synthesis platform to produce silver particles with consistent size and high stability, which are integrated into various healthcare products including antimicrobial wound dressings, medical coatings, and dermatological treatments. Their technology focuses on leveraging the natural antimicrobial properties of silver to combat antibiotic-resistant bacteria and prevent healthcare-associated infections. NanoSilver serves as both a product developer and a supplier of raw nano-silver materials to global partners in the medical device and consumer health sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nano Silver Technologies.